Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell-mediated neuroprotection involves antithrombin activity.

I Friedmann1, E Hauben, E Yoles

  • 1Department of Neurobiology, The Weizmann Institute of Science, 76100, Rehovot, Israel

Journal of Neuroimmunology
|December 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".

Sarcoma·2021
Same author

The first parent-child diagnosis of a multifocal squamous odontogenic tumor: A case report.

Journal of stomatology, oral and maxillofacial surgery·2020
Same author

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

The British journal of dermatology·2020
Same author

Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis.

Sarcoma·2020
Same author

Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

The British journal of dermatology·2019
Same author

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

The British journal of dermatology·2018
Same journal

Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation.

Journal of neuroimmunology·2026
Same journal

Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

Journal of neuroimmunology·2026
Same journal

Serum IDO1 and β-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study.

Journal of neuroimmunology·2026
Same journal

Neurological sequelae of Long COVID: Pathophysiological mechanisms, diagnostic advances, and therapeutic perspectives.

Journal of neuroimmunology·2026
Same journal

Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655].

Journal of neuroimmunology·2026
Same journal

Clinical characteristics of IgG4-related hypertrophic pachymeningitis with and without serum ANCA positivity.

Journal of neuroimmunology·2026
See all related articles

Central nervous system (CNS) injury causes secondary neuronal death due to thrombin toxicity. Autoimmune T cells protect neurons by producing antithrombin III, reducing thrombin

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Secondary neuronal degeneration after central nervous system (CNS) injury is exacerbated by toxic physiological compounds.
  • The protease thrombin is implicated as a key contributor to this post-traumatic neurotoxicity.

Purpose of the Study:

  • To investigate the role of thrombin in post-CNS injury neuronal survival.
  • To explore the neuroprotective mechanisms of autoimmune T cells.
  • To assess the impact of thrombin receptor (PAR-1) modulation on neuronal survival.

Main Methods:

  • Utilized transgenic mice lacking the thrombin receptor PAR-1.
  • Investigated the production of antithrombin III by T cells targeting myelin self-antigens.
  • Assessed neuronal survival and neuroprotection in the context of PAR-1 expression and T cell activity.

Related Experiment Videos

Main Results:

  • Autoimmune T cells promote CNS neuronal survival, partly via antithrombin III production.
  • Genetic down-regulation of PAR-1 in mice enhances post-traumatic CNS neuronal survival.
  • T cell-mediated neuroprotection and thrombin inhibitor production are independent of T cell PAR-1 expression.

Conclusions:

  • Thrombin plays a critical role in neuronal survival following CNS injury.
  • Post-traumatic thrombin toxicity can be mitigated by modulating PAR-1 receptor levels or increasing antithrombin III via T cell-mediated autoimmunity.